The Defense Advanced Research Projects Agency announced a project with the U.S. Army Research Office to develop tissue-integrated biosensor technology.
Profusa, a San Francisco company, was awarded a $7.5 million grant from DARPA to lead the development.
The U.S. military is interested in developing the technology to aid in real-time monitoring of combat soldier health vitals.
Profusa chairman and CEO Ben Hwang said, Profusa s vision is to replace a point-in-time chemistry panel that measures multiple biomarkers, such as oxygen, glucose, lactate, urea, and ions with a biosensor that provides a continuous stream of wireless data,
The U.S. military hopes that this technology will improve mission efficiency and provide real-time information that allows soldiers to quickly address health issues that may affect the mission.
Profusa s bioengineering approach to an implantable biosensor allegedly overcomes the body s natural reaction to reject foreign material.